Use of ceftaroline in complicated methicillin-resistant staphylococcus aureus bacteremia

Hadeel Zainah, Jose A. Vazquez

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Ceftaroline is a novel broad-spectrum cephalosporin approved in October 2010 by the Food and Drug Administration for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by different organisms, including methicillin-resistant Staphylococcus aureus. We report 2 cases where ceftaroline was used effectively to treat complicated methicillin-resistant S aureus bacteremia.

Original languageEnglish (US)
Pages (from-to)58-60
Number of pages3
JournalInfectious Diseases in Clinical Practice
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Keywords

  • MRSA
  • bacteremia
  • ceftaroline

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Use of ceftaroline in complicated methicillin-resistant staphylococcus aureus bacteremia'. Together they form a unique fingerprint.

Cite this